New Role of Atypical Chemokine Receptor 1 in Haematopoiesis
Antal Rot obtained his M.D. at the Semmelweis University, Budapest, Hungary where subsequently he was formally trained as an Anatomical and Surgical Pathologist. His post-doctoral research training was in the lab of legendaryEdward Leonard at the National Cancer Institute, Frederick, USA. Afterwards Antal joined Sandoz/ Novartis Forschungsinstitut in Vienna, Austria where for 20 years he was the Head of Experimental Pathology. After Institute’s closure, Antal moved to the UK taking up successive professorial appointments at the Universities of Birmingham and York. Since July 2017 Antal is the Arthritis Research UK Chair in Inflammation Sciences at the William Harvey Research Institute and the Centre for Inflammation and Therapeutic Innovation, Barts and the London School of Medicine, Queen Mary University of London, Antal’s research interests are related to the molecular and cellular mechanisms of inflammation and the involvement of chemokines, their classical and atypical
receptors in immune response and disease pathogenesis.
Date: 26 September 2017, 13:00 (Tuesday, -1st week, Michaelmas 2017)
Venue: Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details: Bernard Sunley Lecture Theatre
Speaker: Prof. Antal ROT (Queen Mary University)
Organiser: Laura Hume (Kennedy Institute of Rheumatology)
Host: Professor Mike Dustin (Kennedy Institute of Rheumatology)
Booking required?: Not required
Audience: Members of the University only
Editor: Laura Sanchez Lazo